Concentric Capital Strategies’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-66,303
Closed -$3.86M – 380
2025
Q2
$3.86M Buy
+66,303
New +$3.75M 0.17% 145
2024
Q2
– Sell
-17,567
Closed -$954K – 376
2024
Q1
$954K Sell
17,567
-2,379
-12% -$124K 0.05% 245
2023
Q4
$1.12M Sell
19,946
-13,261
-40% -$749K 0.13% 131
2023
Q3
$2.05M Buy
33,207
+16,873
+103% +$1.07M 0.21% 104
2023
Q2
$965K Sell
16,334
-13,666
-46% -$870K 0.19% 120
2023
Q1
$2.22M Buy
+30,000
New +$2.31M 0.73% 58

Other funds holding NTR

Concentric Capital Strategies's NTR Position: Q3 2025 in Review

Concentric Capital Strategies sold out of Nutrien (NTR) in Q3 2025, closing a stake of 66,303 shares — an estimated $3.86M sold.

Concentric Capital Strategies first reported a position in NTR in Q1 2023 and held it in 6 quarters. The position peaked at $3.86M in Q2 2025. 646 funds tracked by Wall St. Rank hold NTR as of Q3 2025.

  • Concentric Capital Strategies reported no remaining Nutrien position as of Q3 2025 after selling out during the quarter.
  • Concentric Capital Strategies sold 66,303 Nutrien shares in Q3 2025, an estimated $3.86M.
  • Concentric Capital Strategies first reported a position in Nutrien in Q1 2023 and held it in 6 quarters.
  • Concentric Capital Strategies's Nutrien position peaked at $3.86M in Q2 2025.
  • 646 funds tracked by Wall St. Rank held Nutrien as of Q3 2025.

Based on Concentric Capital Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.